The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2023 | The second revision of the International Staging System for OS in MM
Mattia D’Agostino, MD, University of Turin, Turin, Italy, briefly discusses the most recent revision of the International Staging System (R2-ISS) of the European Myeloma Network (within the HARMONY project), and comments on how this revised tool will allow for improved risk stratification of patients with multiple myeloma (MM). This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
